ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 397 filers reported holding ENCOMPASS HEALTH CORP in Q4 2019. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $604 | -0.8% | 9 | 0.0% | 0.00% | – |
| Q2 2023 | $609 | +25.1% | 9 | 0.0% | 0.00% | – |
| Q1 2023 | $487 | +62.9% | 9 | +80.0% | 0.00% | – |
| Q4 2022 | $299 | – | 5 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | – | 5 | -28.6% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 7 | -96.9% | 0.00% | -100.0% |
| Q1 2022 | $16,000 | +45.5% | 228 | +37.3% | 0.00% | +50.0% |
| Q4 2021 | $11,000 | -15.4% | 166 | -5.7% | 0.00% | -33.3% |
| Q3 2021 | $13,000 | -7.1% | 176 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $14,000 | 0.0% | 176 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $14,000 | -50.0% | 176 | -48.8% | 0.00% | 0.0% |
| Q4 2020 | $28,000 | +2700.0% | 344 | +1538.1% | 0.00% | – |
| Q3 2020 | $1,000 | 0.0% | 21 | -12.5% | 0.00% | – |
| Q2 2020 | $1,000 | 0.0% | 24 | +71.4% | 0.00% | – |
| Q1 2020 | $1,000 | – | 14 | +366.7% | 0.00% | – |
| Q4 2019 | $0 | – | 3 | -50.0% | 0.00% | – |
| Q2 2019 | $0 | – | 6 | +50.0% | 0.00% | – |
| Q1 2019 | $0 | – | 4 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradice Investment Management LLC | 798,931 | $53,656,206 | 4.60% |
| Orchard Capital Management, LLC | 135,466 | $9,097,897 | 3.36% |
| Sivik Global Healthcare LLC | 90,000 | $6,044 | 3.05% |
| BERNZOTT CAPITAL ADVISORS | 128,663 | $8,641,007 | 2.98% |
| REINHART PARTNERS, LLC. | 746,752 | $50,151,893 | 2.60% |
| Integral Health Asset Management, LLC | 250,000 | $16,790,000 | 2.32% |
| Leeward Investments, LLC - MA | 562,001 | $37,743,987 | 1.93% |
| Copeland Capital Management, LLC | 1,277,690 | $85,809,665 | 1.84% |
| Magnetar Financial LLC | 1,060,733 | $71,238,828 | 1.82% |
| Advantage Alpha Capital Partners LP | 122,252 | $8,210,444 | 1.72% |